Rivaroxaban vs Apixaban and Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation

被引：0
|
作者：
Ray, Wayne A. [1 ]
Murray, Katherine T. [2 ]
机构：
[1] Vanderbilt Univ, Dept Hlth Policy, Sch Med, Nashville, TN USA
[2] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2022年 / 327卷 / 13期
关键词：
D O I：
10.1001/jama.2022.1425
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1290 / 1290
页数：1
相关论文
共 50 条
  • [41] Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation
    Andersson, Niklas W.
    Svanstrom, Henrik
    Lund, Marie
    Pasternak, Bjorn
    Melbye, Mads
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 268 : 113 - 119
  • [42] Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation
    Martinez, Brandon K.
    Sood, Nitesh A.
    Bunz, Thomas J.
    Coleman, Craig I.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (08):
  • [43] EFFECTIVENESS AND SAFETY OF APIXABAN, DABIGATRAN AND RIVAROXABAN VERSUS WARFARIN IN FRAIL PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION
    Coleman, Craig I.
    Turpie, Alexander
    Bunz, Thomas J.
    Sood, Nitesh
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 290 - 290
  • [44] Effectiveness and Safety of Apixaban versus Rivaroxaban in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus
    Chowdhury, Krishna Roy
    Michaud, Jonathan
    Yu, Oriana Hoi Yun
    Yin, Hui
    Azoulay, Laurent
    Renoux, Christel
    THROMBOSIS AND HAEMOSTASIS, 2022, 122 (10) : 1794 - 1803
  • [45] Cerebral Ischemic and Hemorrhagic Events in Patients with Atrial Fibrillation on Warfarin: A Prospective Multi-Centre Study
    Paciaroni, Maurizio
    Agnelli, Giancarlo
    Ageno, Walter
    Caso, Valeria
    Corea, Francesco
    Lanari, Alessia
    Alberti, Andrea
    Previdi, Paolo
    Fedele, Marta
    Manina, Giorgia
    Vedovati, Cristina
    Venti, Michele
    Billeci, Antonia M. R.
    Batta, Maurizio
    Silvestrelli, Giorgio
    NEUROLOGY, 2010, 74 (09) : A484 - A485
  • [46] History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial
    De Caterina, Raffaele
    Andersson, Ulrika
    Alexander, John H.
    Al-Khatib, Sana M.
    Bahit, M. Cecilia
    Goto, Shinya
    Hanna, Michael
    Held, Claes
    Hohnloser, Stefan
    Hylek, Elaine M.
    Lanas, Fernando
    Lopes, Renato D.
    Lopez-Sendon, Jose
    Renda, Giulia
    Horowitz, John
    Granger, Christopher B.
    Wallentin, Lars
    AMERICAN HEART JOURNAL, 2016, 175 : 175 - 183
  • [47] Thromboembolic and hemorrhagic events among patients with nonvalvular atrial fibrillation
    Darkow, T
    Vanderplas, A
    Kim, J
    Hauch, O
    CIRCULATION, 2004, 109 (20) : E258 - E258
  • [48] APIXABAN REDUCES HOSPITALIZATION IN PATIENTS WITH ATRIAL FIBRILLATION: AN ANALYSIS OF THE EFFECT OF APIXABAN THERAPY ON RESOURCE USE IN THE APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION TRIAL
    Cowper, Patricia A.
    Pan, Wenqin
    Anstrom, Kevin
    Stafford, Judith
    Lopes, Renato
    Davidson-Ray, Linda
    Wallentin, Lars
    Phatak, Hemant
    Ansell, Jack
    Dorian, Paul
    Husted, Steen
    McMurray, John
    Steg, P. Gabriel
    Alexander, John
    Granger, Christopher
    Mark, Daniel
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1576 - E1576
  • [49] Early Apixaban Therapy After Ischemic Stroke in Patients With Atrial Fibrillation.
    Alrohimi, Anas
    Buck, Brian H.
    Jickling, Glen
    Shuaib, Ashfaq
    Thirunavukkarasu, Sibi
    Butcher, Ken
    STROKE, 2021, 52
  • [50] Apixaban Patients with Atrial Fibrillation protective
    Koczorek, Michael
    ZEITSCHRIFT FUR ORTHOPADIE UND UNFALLCHIRURGIE, 2012, 150 (03): : 247 - 247
12345